FAU.de
Deutsch
Login
Home
Publications
Research Grants
Inventions & Patents
Awards
Additional Research Activities
Faculties & Institutions
Research Areas
Lehrstuhl für Klinische und Molekulare Virologie
Friedrich-Alexander-Universität Erlangen-Nürnberg
Medizinische Fakultät
Einrichtungen, die zum Universitätsklinikum Erlangen gehören
Institute of Clinical and Molecular Virology
Overview
Publications
(415)
Research Grants
(9)
Types of publications
Toggle all
Journal article
Journal article
Book chapter / Article in edited volumes
Book chapter / Article in edited volumes
Authored book
Authored book
Translation
Translation
Thesis
Thesis
Edited Volume
Edited Volume
Conference contribution
Conference contribution
Other publication type
Other publication type
Unpublished / Preprint
Unpublished / Preprint
Publication year
From
To
Abstract
Journal
Filters (inactive)
Neutralizing Antibodies Limit Cell-Associated Spread of Human Cytomegalovirus in Epithelial Cells and Fibroblasts (2022)
Reuter N, Kropff B, Britt WJ, Mach M, Thomas M
Journal article
Bornavirus encephalitis as a differential diagnosis to seronegative autoimmune encephalitis (2022)
Meier H, Bauer C, Finkenzeller W, Nentwich J, Staedt M, Steininger P, Korn K, et al.
Journal article
Three exposures to the spike protein of SARS-CoV-2 by either infection or vaccination elicit superior neutralizing immunity to all variants of concern (2022)
Wratil PR, Stern M, Priller A, Willmann A, Almanzar G, Vogel E, Feuerherd M, et al.
Journal article
Covalent coupling of HIV-1 glycoprotein trimers to biodegradable calcium phosphate nanoparticles via genetically encoded aldehyde-tags (2022)
Damm D, Kostka K, Weingärtner C, Wagner J, Rojas-Sánchez L, Gensberger-Reigl S, Sokolova V, et al.
Journal article
Antiviral Strategies Using Natural Source-Derived Sulfated Polysaccharides in the Light of the COVID-19 Pandemic and Major Human Pathogenic Viruses (2022)
Ray B, Ali I, Jana S, Mukherjee S, Pal S, Ray S, Schütz M, Marschall M
Journal article
Anti-SARS-CoV-2 Inhibitory Profile of New Quinoline Compounds in Cell Culture-Based Infection Models (2021)
Herrmann L, Hahn F, Wangen C, Marschall M, Tsogoeva S
Journal article
Development of a PROTAC-based targeting strategy provides a mechanistically unique mode of anti-cytomegalovirus activity (2021)
Hahn F, Hamilton ST, Wangen C, Wild M, Kicuntod J, Brückner N, Follett JE, et al.
Journal article
Iota-carrageenan inhibits replication of sars-cov-2 and the respective variants of concern alpha, beta, gamma and delta (2021)
Fröba M, Große M, Setz C, Rauch P, Auth J, Spanaus L, Münch J, et al.
Journal article
Protective mucosal immunity against SARS-CoV-2 after heterologous systemic prime-mucosal boost immunization (2021)
Lapuente D, Fuchs J, Willar J, Vieira Antao AI, Eberlein V, Uhlig N, Issmail L, et al.
Journal article
Interleukin-3 is a predictive marker for severity and outcome during SARS-CoV-2 infections (2021)
Bénard A, Jacobsen A, Brunner M, Krautz C, Klösch B, Swierzy I, Naschberger E, et al.
Journal article
‹
1
...
8
9
10
11
12
...
42
›